4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-048165
SVP and General Counsel sold 2,880 shares at an average $42.58 ($122,635)
- SVP and General Counsel acquired 2,880 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Taylor Stacy L SVP and General Counsel | 2020-08-24 | Option exercise | +1,109 | $7.80 | $8,650 | 2,409 | D |
| Taylor Stacy L SVP and General Counsel | 2020-08-24 | Option exercise | +1,771 | $6.55 | $11,600 | 4,180 | D |
| Taylor Stacy L SVP and General Counsel | 2020-08-24 | Sale | −1,260 | $42.07 | $53,008 | 2,920 | D |
| Taylor Stacy L SVP and General Counsel | 2020-08-24 | Sale | −1,400 | $42.92 | $60,088 | 1,520 | D |
| Taylor Stacy L SVP and General Counsel | 2020-08-24 | Sale | −220 | $43.36 | $9,539 | 1,300 | D |
| Derivatives | |||||||
| Taylor Stacy L SVP and General Counsel | 2020-08-24 | Option exercise · Stock Option (Right to Buy) | −1,109 | 37,254 | D | ||
| Taylor Stacy L SVP and General Counsel | 2020-08-24 | Option exercise · Stock Option (Right to Buy) | −1,771 | 33,646 | D | ||
| Open-market sales · 2,880 sh · avg $42.58 · $122,635 | |||||||
Loading xslF345X03/doc4.xml…